AllianceBernstein’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-54,000
| Closed | -$849K | – | 3335 |
|
|
2024
Q1 | $849K | Buy |
54,000
+4,300
| +9% | +$66.2K | ﹤0.01% | 2352 |
|
|
2023
Q4 | $802K | Sell |
49,700
-343
| -0.7% | -$4.38K | ﹤0.01% | 2382 |
|
|
2023
Q3 | $637K | Hold |
50,043
| – | – | ﹤0.01% | 2452 |
|
|
2023
Q2 | $705K | Hold |
50,043
| – | – | ﹤0.01% | 2467 |
|
|
2023
Q1 | $773K | Hold |
50,043
| – | – | ﹤0.01% | 2350 |
|
|
2022
Q4 | $820K | Hold |
50,043
| – | – | ﹤0.01% | 2380 |
|
|
2022
Q3 | $926K | Buy |
50,043
+343
| +0.7% | +$5.38K | ﹤0.01% | 2329 |
|
|
2022
Q2 | $654K | Hold |
49,700
| – | – | ﹤0.01% | 2557 |
|
|
2022
Q1 | $461K | Sell |
49,700
-5,500
| -10% | -$46.8K | ﹤0.01% | 2717 |
|
|
2021
Q4 | $539K | Hold |
55,200
| – | – | ﹤0.01% | 2711 |
|
|
2021
Q3 | $1.88M | Hold |
55,200
| – | – | ﹤0.01% | 2208 |
|
|
2021
Q2 | $2.02M | Sell |
55,200
-1,937,506
| -97% | -$75M | ﹤0.01% | 2186 |
|
|
2021
Q1 | $89.4M | Buy |
1,992,706
+487,445
| +32% | +$22.7M | 0.04% | 437 |
|
|
2020
Q4 | $85.9M | Sell |
1,505,261
-39,575
| -3% | -$2.35M | 0.04% | 422 |
|
|
2020
Q3 | $79.3M | Buy |
1,544,836
+191,759
| +14% | +$9.39M | 0.04% | 392 |
|
|
2020
Q2 | $80.8M | Buy |
1,353,077
+90,580
| +7% | +$4.85M | 0.05% | 382 |
|
|
2020
Q1 | $52M | Buy |
1,262,497
+4,786
| +0.4% | +$266K | 0.04% | 432 |
|
|
2019
Q4 | $78.3M | Sell |
1,257,711
-87,313
| -6% | -$4.15M | 0.04% | 402 |
|
|
2019
Q3 | $45.6M | Buy |
1,345,024
+1,318,924
| +5,053% | +$39M | 0.03% | 552 |
|
|
2019
Q2 | $589K | Sell |
26,100
-496,781
| -95% | -$11.6M | ﹤0.01% | 2534 |
|
|
2019
Q1 | $12.1M | Sell |
522,881
-96,437
| -16% | -$2.52M | 0.01% | 973 |
|
|
2018
Q4 | $13M | Buy |
619,318
+34,901
| +6% | +$858K | 0.01% | 893 |
|
|
2018
Q3 | $22.6M | Buy |
584,417
+108,871
| +23% | +$4.02M | 0.01% | 752 |
|
|
2018
Q2 | $18.7M | Buy |
+475,546
| New | +$14M | 0.01% | 798 |
|
|
2018
Q1 | – | Sell |
-25,000
| Closed | -$567K | – | 3059 |
|
|
2017
Q4 | $567K | Buy |
+25,000
| New | +$490K | ﹤0.01% | 2492 |
|
Other funds holding DCPH
AllianceBernstein's DCPH Position: Q2 2024 in Review
AllianceBernstein sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 54,000 shares — an estimated $849K sold.
AllianceBernstein first reported a position in DCPH in Q4 2017 and held it in 25 quarters. The position peaked at $89.4M in Q1 2021. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- AllianceBernstein reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- AllianceBernstein sold 54,000 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $849K.
- AllianceBernstein first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 25 quarters.
- AllianceBernstein's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $89.4M in Q1 2021.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on AllianceBernstein's 13F filing for Q2 2024, filed 14 Aug 2024.